Investment
Features
FeesSafety
Academy
More
Pluang+

Golden Sky Minerals finds strong copper soil anomalies linked to intrusive rocks at Rayfield-Gjoll project.

Market News
14 Sep 2026
Newsfile Corp
View Source
Bullish
Golden Sky Minerals finds strong copper soil anomalies linked to intrusive rocks at Rayfield-Gjoll project.

Golden Sky Minerals reported strong copper-in-soil anomalies at its Rayfield-Gjoll Project in British Columbia, closely associated with intrusive rocks like diorite and monzonite. These findings support a porphyry copper-gold exploration model and highlight priority areas for further geological mapping and sampling. The project area was also expanded by about 7,300 hectares to cover more prospective structures. This progress strengthens the geological framework and guides next exploration phases.

Golden Sky Minerals' recent copper-in-soil findings provide context for readers interested in basic materials. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 15, 2026 10:02 WIB: of 32 priced US stocks, 1 rose and 31 fell. Notable prices include Barrick Gold Corp at USD 42.52 with a -2.66% change, ArcelorMittal SA at USD 72.72 with a -2.40% change, and Icl Group Ltd at USD 5.53 with a -2.30% change.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
47 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
Nelnet Business Services acquires Indian school tech firm Entab to expand in K-12 education market.

Nelnet Business Services acquires Indian school tech firm Entab to expand in K-12 education market.

Nelnet Business Services (NBS) has acquired Entab Infotech, a leading Indian provider of school administration and learning technology software. This acquisition supports NBS's international growth strategy by entering India’s large K-12 education ma...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App